The expanding spectrum of aetiologies causing retinal microcystic macular change.

نویسندگان

  • Pavan Bhargava
  • Peter A Calabresi
چکیده

In this issue of Brain, John Kisimbi et al. (2013) describe spectral domain optical coherence tomography (OCT) findings in a cohort of patients with Tanzanian endemic optic neuropathy, a disorder of unknown aetiology, leading to severe bilateral subacute optic neuropathy. They describe severe retinal nerve fibre layer (RNFL) thinning and concomitant microcystic macular changes in 12.5% of this cohort. The authors describe a parafoveal annular or semi-lunar pattern of the microcystic (perhaps a misnomer but the term will be used for consistency in the literature) changes with a pre-dilection for the nasal aspect of the macula visible using en face infrared imaging. This distribution of microcystic macular change is consistent with that described in previous contexts (Abegg et al., 2012; Kaufhold et al., 2013; Wolff et al., 2013). The current study by Kisimbi et al. (2013) adds Tanzanian endemic optic neuropathy to a growing list of aetiologies causing microcystic macular changes. Histopathological changes similar in appearance to microcystic macular change were described as early as 1963 by John Van Buren, who observed cystic changes in the retinal inner nuclear layer of non-human primates following optic nerve injury. Similar changes to the inner nuclear layer of human eyes with optic nerve lesions were subsequently demonstrated by Gills and Wadsworth (1966). A more recent study demonstrated inner nuclear layer cavitation and cystic changes in rhesus macaques with bilateral idiopathic optic atrophy (Fortune et al., 2005). Microcystic macular changes on OCT were described in patients with multiple sclerosis and correlated with disease severity (Gelfand et al., 2012; Saidha et al., 2012). These studies were followed by a flurry of Letters to the Editor demonstrating morphologically similar microcystic macular changes in a variety of inflammatory and non-inflammatory optic neuropathies. Microcystic macular changes have now been described in multiple sclerosis, neuromyelitis optica, Leber's hereditary optic neuropathy, dominant optic atrophy, isolated relapsing optic neuropathy, NF-1-related optic chiasmal glioma, glaucoma, trauma and hydro-cephalus (Abegg et al. Furthermore, microcystic changes are also described in patients undergoing internal limiting membrane removal for epima-cular membrane—possibly secondary to damage to the RNFL and the ganglion cell layer (Sigler et al., 2013). Several different theories have been advanced to explain the pathophysiology of retinal microcystic changes. One of the most attractive explanations, is retrograde trans-synaptic degeneration. Retrograde trans-synaptic degeneration in the visual pathways secondary to occipital lobe damage was demonstrated by Jindahra et al. (2012). By extension, this could be hypothesized to …

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The clinical spectrum of microcystic macular edema.

PURPOSE Microcystic macular edema (MME), originally described in British literature as microcystic macular oedema (MMO), defines microcysts in the inner nuclear layer (INL) of the retina. Microcystic macular edema was described in multiple sclerosis (MS), but can be found in numerous disorders. The presence of MME has important prognostic and therapeutic implications; however, the differential ...

متن کامل

Microcystic macular oedema in multiple sclerosis is associated with disease severity.

Macular oedema typically results from blood-retinal barrier disruption. It has recently been reported that patients with multiple sclerosis treated with FTY-720 (fingolimod) may exhibit macular oedema. Multiple sclerosis is not otherwise thought to be associated with macular oedema except in the context of comorbid clinical uveitis. Despite a lack of myelin, the retina is a site of inflammation...

متن کامل

Microcystic macular degeneration from optic neuropathy.

Sir, We read with great interest the article by Gelfand et al. (2012) in the June issue of Brain. The authors described in detail vacuolar macular changes in the inner nuclear layer of patients with multiple sclerosis. This ‘microcystic macular oedema’ was associated with decreased visual acuity and a higher disability score. We found similar microcysts in the macular inner nuclear layer of a 1...

متن کامل

Microcystic macular oedema confirmed, but not specific for multiple sclerosis.

Sir, a potentially new sign in multiple sclerosis was described in Brain (Gelfland et al., 2012). This new sign, microcystic macular oedema, is intriguing because it is considered to indicate breakdown of the blood-retinal barrier with or without microglial inflammation (Gelfland et al., 2012). There are earlier reports on vascular instability and leakage during inflammation in multiple scleros...

متن کامل

Cell based therapies in retinal diseases

Background Degenerative retinal diseases, including age related macular degeneration, glaucoma, and hereditary retinal dystrophies are major causes of blindness. The principal defect in these diseases is cell loss which is amenable to both cell based neuroprotective and neuroregenerative therapies. To briefly review the lines of research and potential candidates for cell based therapies among ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Brain : a journal of neurology

دوره 136 Pt 11  شماره 

صفحات  -

تاریخ انتشار 2013